Executive Moves | Healthcare | BioTuesdays by Kilmer Lucas IR

Executive Moves

Benjamin Bowen joins Roth’s healthcare investment banking team

Benjamin Bowen Benjamin Bowen, Ph.D., has joined Roth Capital Partners as managing director, healthcare investment banking. Prior to joining Roth, Dr. Bowen most recently was managing director in the investment banking...

December 4, 2020

Executive Moves

Profound Medical appoints accomplished financial executive, Murielle Lortie, to board

Murielle Lortie Profound Medical (NASDAQ:PROF; TSX:PRN) appointed financial executive, Murielle Lortie, as a director, effective immediately. Ms. Lortie is the CFO of Liminal Biosciences, a Nasdaq-listed, clinical-stage...

November 30, 2020

Executive Moves

ObsEva names Brian O’Callaghan as CEO

Brian O’Callaghan ObsEva (NASDAQ:OBSV) appointed Brian O’Callaghan as CEO, effective Dec. 1. He succeeds ObsEva’s co-founder, Ernest Loumaye, M.D., Ph.D., who is retiring from his role as CEO but will remain a...

November 9, 2020

Executive Moves

Marizyme names Neil Campbell as president and CEO

Marizyme (NASDAQ:MRZM) appointed Neil Campbell, Ph.D., as CEO, replacing executive chairman James Sapirstein, who has been the company’s interim CEO since September 2020. Dr. Campbell currently serves as chairman of...

November 6, 2020

Executive Moves

LogicBio names Mariana Nacht as CSO; Kyle Chiang as COO

LogicBio Therapeutics (NASDAQ:LOGC) appointed Mariana Nacht, Ph.D., as CSO, effective Nov. 30; and promoted Kyle Chiang, Ph.D., to the role of COO, effective Nov. 2. The company is expanding its leadership team to...

November 3, 2020

Executive Moves

Aethlon Medical names Charles Fisher as CEO

Aethlon Medical (NASDAQ:AEMD) appointed Charles Fisher, M.D., as CEO, effective Oct. 30. Dr. Fisher joined Aethlon as a member of its board and served as its chairman since November 2017. He succeeds Dr. Timothy Rodell...

November 3, 2020

Executive Moves

Soliton appoints Brad Hauser as president, CEO

Brad Hauser Soliton (NASDAQ:SOLY) named Brad Hauser as president and CEO as the company prepares for its commercial launch. Mr. Hauser most recently was VP of R&D and general manager for CoolSculpting at Allergan...

November 2, 2020

Executive Moves

Fibrocor names William Fanslow as SVP drug development

William Fanslow Closely-held Fibrocor Therapeutics appointed industry veteran, William Fanslow Ph.D., as SVP of drug development. Dr. Fanslow has more than 20 years of experience in drug development, including both...

October 26, 2020

Executive Moves

Perimeter Medical Imaging AI names Jeremy Sobotta as CEO; Tom Boon as COO

Perimeter Medical Imaging AI (TSXV:PINK; FSE:4PC) appointed Jeremy Sobotta as its new CEO and Tom Boon as its new COO, effective immediately. Mr. Sobotta was most recently Perimeter’s CFO and replaces Tom Boon as CEO...

October 22, 2020

Executive Moves

Long-time biotech analyst Doug Loe joins Leede Jones Gable

Doug Loe, Ph.D. has joined Leede Jones Gable as it continues to grow its capital markets team, boosting healthcare and biotechnology, and building on recent additions in sales and trading. Dr. Loe, who brings more than...

October 14, 2020

Executive Moves

Kaleido Biosciences names Daniel Menichella as president and CEO

Daniel Menichella Kaleido Biosciences (NASDAQ:KLDO) appointed Daniel Menichella as president and CEO, effective Oct. 13. Mr. Menichella will replace Alison Lawton, who is stepping down for personal reasons...

October 1, 2020

Executive Moves

PharmaJet appoints Melissa Malhame as VP business development

Melissa Malhame Closely-held PharmaJet appointed Melissa Malhame as its VP of business development, where she will lead the company’s business development, sales, and marketing operations. “[Ms. Malhame’s] strategic...

September 29, 2020

Executive Moves

Eric Cheng joins Altium Capital as a managing director

After 23 years in investment banking, Eric Cheng has joined Altium Capital Management, an investment firm based in New York focused on the healthcare industry. Mr. Cheng most recently was managing director and head of...

September 1, 2020

Executive Moves

Perimeter Medical Imaging names Aaron Davidson to its board

Aaron Davidson Perimeter Medical Imaging (TSXV:PINK) appointed Aaron Davidson, currently CFO and SVP of corporate development at Profound Medical (TSX-V:PRN; OTCQX:PRFMF), to its board of directors. “[Mr...

August 26, 2020

Executive Moves

Kane Biotech appoints renowned wound care and biofilms expert, Dr. Gregory Schultz, as scientific advisor

Kane Biotech (TSX-V:KNE) appointed wound care and biofilms expert, Dr. Gregory Schultz, as a scientific advisor. Dr. Schultz is the director of the Institute for Wound Research and professor of obstetrics and gynecology...

August 12, 2020

Executive Moves

Pacific Biosciences names Christian Henry as president and CEO

Christian Henry Pacific Biosciences (NASDAQ:PACB) appointed Christian Henry as president and CEO, effective Sept. 14. Mr. Henry will replace Michael Hunkapiller, who will retire at the end of 2020. Current...

August 7, 2020

Executive Moves

Zenabis names Shai Altman as president and CEO

Shai Altman Zenabis Global (TSX:ZENA) appointed Shai Altman as president and CEO, effective September 1. Mr. Altman will replace interim CEO, Kevin Coft, who will return to his role as Zenabis’ chief...

July 31, 2020

Executive Moves

Canaccord boosts healthcare investment banking team

Canaccord Genuity named Thomas O’Connor as managing director, co-head of U.S. healthcare investment banking, with long-time partners, Matt Steere and Eugene Rozelman, joining Mr. O’Connor as fellow co-heads of the U.S...

July 23, 2020

Executive Moves

Rhythm Pharma appoints Dr. David Meeker as CEO

David Meeker Rhythm Pharmaceuticals (NASDAQ:RYTM) appointed its chairman, Dr. David Meeker as CEO, effective immediately. Dr. Meeker replaces interim president and CEO, Hunter Smith, who will continue in his role as CFO...

July 20, 2020

Executive Moves

Sun BioPharma names Jennifer Simpson as president and CEO

Jennifer Simpson Sun BioPharma (OTCQB:SNBP) appointed Jennifer Simpson as president and CEO, replacing co-founder Michael Cullen, who will continue to serve as the company’s executive chairman. Dr. Simpson has more than...

July 17, 2020

Executive Moves

Neuronetics names Keith Sullivan as president and CEO

Keith Sullivan Neuronetics (NASDQ:STIM) appointed Keith Sullivan as president and CEO, effective immediately. Christopher Thatcher, the company’s previous president and CEO, resigned in March 2020. Mr. Sullivan has more...

July 14, 2020

Executive Moves

Elemer Piros rejoins Roth healthcare research team

Elemer Piros Elemer Piros has rejoined the healthcare research team at Roth Capital Partners as managing director, senior research analyst covering biotechnology. His research coverage is expected to include small...

July 9, 2020

Subscribe